Trial Search Results

Initiation of Continuous Glucose Monitoring at Diagnosis of Type 1 Diabetes

The purpose of this study is to learn about the impact of continuous glucose monitoring (CGM) on families with newly diagnosed children with type 1 diabetes (T1D). The investigators hope to learn about how continuous glucose monitoring affects glycemic variables and diabetes-related distress.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Korey Hood

Collaborator: University of Colorado, Denver

Stanford Investigator(s):

Intervention(s):

  • Device: CGM at diagnosis of T1D

Phase:

N/A

Eligibility


Inclusion Criteria:

To be eligible for the study, a child must meet the following criteria:

   1. Diagnosis of type 1 diabetes according to American Diabetes Association diagnostic
   criteria

   2. Time since diagnosis of no longer than one month

   3. Age between 2 and 17 years

   4. Parental consent (and assent from the child where applicable) to participate in the
   study

   5. No severe medical conditions, which in the opinion of the investigators are likely to
   hinder participation in this clinical trial.

To be eligible for the study, a parent must meet the following criteria:

   1. Parent or legal guardian of a child with type 1 diabetes meeting the "child" criteria
   outlined above

   2. Age of 18.0 years or older

   3. Parent comprehends written English

   4. Parent understands the study protocol and signs the informed consent document

Exclusion Criteria:

The presence of any of the following is an exclusion for the study:

   1. Child has a medical disorder that in the judgment of the investigator will interfere
   with completion of any aspect of the protocol (e.g., pregnancy, kidney disease,
   adrenal insufficiency, skin condition that may hinder sensor application).

   2. Child has a neurologic disorder that in the judgment of the investigator will affect
   completion of the protocol

   3. Current use of oral glucocorticoids or other medications, which in the judgment of the
   investigator would be a contraindication to participation in the study

   4. Child is unable to completely avoid acetaminophen for duration of study

Ages Eligible for Study

2 Years - 17 Years

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Sarah Hanes
650-736-6661
Recruiting